Augmented vasoconstriction and thromboxane formation by 15-F(2t)- isoprostane (8-iso-prostaglandin F(2α)) in immature pig periventricular brain microvessels

Stroke

Volumn 31, Issue 2, 2000, Pages 516-525

  Hou, Xin ^a   Gobeil Jr , Fernand ^a,c   Peri, Krishna ^a   Speranza, Giovanna ^a,b   Marrache, Anne Marilise ^a,b   Lachapelle, Pierre ^b   Roberts II, Jackson ^c   Varma, Daya R ^b   Chemtob, Sylvain ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Fetus; Ischemia; Newborn; Peroxidation; Prostaglandins

Indexed keywords

ISOPROSTANE; THROMBOXANE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CONTROLLED STUDY; ENDOTHELIUM CELL; FETUS; MICROVASCULATURE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PREMATURITY; PRIORITY JOURNAL; SWINE; VASOCONSTRICTION;

EID: 0033966071     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.str.31.2.516     Document Type: Article

References (48)

1. Southorn PA, Powis G. Free radicals in medicine, I: chemical nature and biological reaction; II: involvement in human disease. Mayo Clin Proc. 1988;63:381-408.
2. Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Pediatr Neurol. 1998; 5:135-151.
3. Sullivan JL. Iron, plasma antioxidants, and the oxygen radical disease of prematurity. Am J Dis Child. 1988;142:1341-1344.
4. Taylor DL, Edwards AD, Mehmet H. Oxidative metabolism, apoptosis and perinatal brain injury. Brain Pathol. 1999;9:93-117.
5. Noseworthy MD, Bray TM. Effect of oxidative stress on brain damage detected by MRI and in vivo 31P-NMR. Free Radic Biol Med. 1998;24: 942-951.
6. Vannucci RC, Perlman JM. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics. 1997;100:1004-1014.
7. Hoffman SW, Moore S, Ellis EF. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke. 1997;28:844-849.
8. Sano K, Asano T, Tanishima T, Sasaki T. Lipid peroxidation as a cause of cerebral vasospasm. Neurol Res. 1980;2:253-272.
9. Abran D, Varma DR, Chemtob S. Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides. Am J Physiol. 1995;268(Heart Circ Physiol. 37):H628-H632.
10. Chemtob S, Hardy P, Abran D, Li DY, Peri K, Cuzzani O, Varma DR. Peroxide cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics. J Appl Physiol. 1995;78:2039-2046.
11. 2 effects on cerebral prostanoids and pial arteriolar diameter in piglets. Am J Physiol. 1990;258(Heart Circ Physiol. 27):H1382-H1387.
12. Tate RM, Morris HG, Schroeder WR, Repine JE. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. J Clin Invest. 1984;74:608-613.
13. Morrow JD, Roberts LJ II. The isoprostanes: current knowledge and directions for future research. Biochem Pharmacol. 1996;51:1-9.
14. Roberts LJ II, Morrow JD. Generation and actions of isoprostanes. Biochim Biophys Acta. 1997;1345:121-135.
15. Morrow JD, Roberts LJ II. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res. 1997;36:1-36.
16. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A. 1992;89:10721-10725.
17. 2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem Pharmacol. 1994;47:1173-1177.
18. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A. 1990;87:9383-9387.
19. 2-isoprostane production and cytolysis in renal tubular epithelial cells. J Am Soc Nephrol. 1995;6: 1300-1303.
20. Taber DF, Morrow JD, Roberts LJ II. A nomenclature system for the isoprostanes. Prostaglandins. 1997;53:63-67.
21. Lahaie I, Hardy P, Hou X, Hassessian H, Asselin P, Lachapelle P, Almazan G, Varma DR, Morrow JD, Roberts LJ II, Chemtob S. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am J Physiol. 1998;274(pt 2):R1406-R1416.
22. 2a, in rabbit lung in situ. Am J Physiol. 1992;263(Heart Circ Physiol. 32):H660-H663.
23. 2a in isolated perfused rat lung. J Appl Physiol. 1993;74:460-465.
24. 2a. Br J Phamacol. 1996;119:1276-1280.
25. 2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol. 1993;264(Cell Physiol. 33): C1619-C1624.
26. 2a is not mediated by thromboxane receptor isoforms. J Biol Chem. 1996;271:14916-14924.
27. 2. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:237-239.
28. 2 alpha in rat aortic rings. Prostaglandins. 1997;54:581-599.
29. Li DY, Hardy P, Abran D, Martinez-Bermudez AK, Guerguerian AM, Bhattacharya M, Almazan G, Menezes R, Peri KG, Varma DR, Chemtob S. Key role for cyclooxygenase-2 in PGE2 and PGF2 alpha receptor regulation and cerebral blood flow of the newborn. Am J Physiol. 1997; 273(pt 2):R1283-R1290.
30. Li DY, Abran D, Peri KG, Varma DR, Chemtob S. Inhibition of prostaglandin synthesis in newborn pigs increases cerebral microvessel prostaglandin F2 alpha and prostaglandin E2 receptors, their second messengers and vasoconstrictor response to adult levels. J Pharmacol Exp Ther. 1996;278:370-377.
31. Harper SL, Bohlen HG, Rubin MJ. Arterial and microvascular contributions to cerebral cortical autoregulation in rats. Am J Physiol. 1984; 246:H17-H24.
32. Fox JA. Novel omega-conopeptides reduced field potential amplitudes in the rat hippocampal slice. Neurosci Lett. 1994;165:157-160.
33. 2 inhibitors. In: Bailey JM, ed. Prostaglandins, Leukotrienes and Lipoxins. New York. NY: Plenum Press; 1985: 669-676.
34. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, Leigh BK, McCarthy SA, Moores KE, Rink TJ. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J. 1990;271:515-522.
35. Rivier J, Galyean R, Gray WR, Azimi-Zonooz A, McIntosh JM, Cruz LJ, Olivera BM. Neuronal calcium channel inhibitors: synthesis of omega-conotoxin GVIA and effects on 45Ca uptake by synaptosomes. J Biol Chem. 1987;262:1194-1198.
36. Himmel HM, Whorton AR, Strauss HC. Intracellular calcium, currents, and stimulus-response coupling in endothelial cells. Hypertension. 1993; 21:112-127.
37. Fern R. Intracellular calcium and cell death during ischemia in neonatal rat white matter astrocytes in situ. J Neurosci. 1998;18:7232-7243.
38. Porter JT, McCarthy KD. Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals. J Neurosci. 1996;16: 5073-5081.
39. 2 alpha receptor density in brain microvessels of pigs. Br J Pharmacol. 1994;112:59-64.
40. Almazan G, Afar DE, Bell JC. Phosphorylation and disruption of intermediate filament proteins in oligodendrocyte precursor cultures treated with calyculin A. J Neurosci Res. 1993;36:163-172.
41. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985; 260:3440-3450.
42. Peri K, Hardy P, Li DY, Varma DR, Chemtob S. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn. J Biol Chem. 1995;270:24615-24620.
43. 2+ channels in reactive astrocytes after brain injury, hypomyelination, and ischemia. J Neurosci. 1998;18: 2321-2334.
44. McDonough W, Tran N, Giese A, Norman SA, Berens ME. Altered gene expression in human astrocytoma cells selected for migration, I: thromboxane synthase. J Neuropathol Exp Neurol. 1998;57:449-455.
45. Murphy S, Pearce B, Jeremy J, Dandona P. Astrocytes as eicosanoid-producing cells. Glia. 1988;1:241-245.
46. Harder DR, Alkayed NJ, Lange AR, Gebremedhin D, Roman RJ. Functional hyperemia in the brain: hypothesis for astrocyle-derived vasodilator metabolites. Stroke. 1998;29:229-234.
47. Ment LR, Stewart WB, Petroff OA, Duncan CC. Thromboxane synthesis inhibitor in a beagle pup model of perinatal asphyxia. Stroke. 1989;20: 809-814.
48. Iijima T, Sawa H, Shiokawa Y, Saito I, Ishii H, Nakamura Z,. Sankawa H. Thromboxane synthetase inhibitor amelioraies delayed neuronal death in the CA1 subfield of the hippocampus after transient global ischemia in gerbils. J Neurosurg Anesthesiol. 1996;8:237-242.